Clinical Neurovirology

Author:   Avindra Nath (Nat. Inst. of Health, USA) ,  Joseph R. Berger (University of Pennsylvania, Philadelphia, USA)
Publisher:   Taylor & Francis Inc
Edition:   2nd edition
ISBN:  

9781498733168


Pages:   452
Publication Date:   14 May 2020
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $336.00 Quantity:  
Add to Cart

Share |

Clinical Neurovirology


Add your own review!

Overview

Full Product Details

Author:   Avindra Nath (Nat. Inst. of Health, USA) ,  Joseph R. Berger (University of Pennsylvania, Philadelphia, USA)
Publisher:   Taylor & Francis Inc
Imprint:   CRC Press Inc
Edition:   2nd edition
Weight:   1.632kg
ISBN:  

9781498733168


ISBN 10:   1498733166
Pages:   452
Publication Date:   14 May 2020
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

This second edition is a wonderful comprehensive reference for practicing neurologists and infectious disease specialists when faced with patients afflicted with viral-mediated neurological syndromes. A significant upgrade from the first edition, this edition includes newer topics, including West Nile, Ebola, Zika, enterovirus D68, and SARS-CoV-2 viruses, as well as significant advances in methodologies of detection and treatment. Drs. Nath and Berger have provided a very broad coverage to this topic, reflecting their clinical and scientific background, keeping both the clinical and scientific practitioners in mind. This text holds its own as a solidly comprehensive reference text for clinicians, including neurologists and infectious disease specialists, as well as for the immunologist and clinical scientist involved in the pathophysiology of virally mediated neurological illnesses. The editors are well-renowned neuroinfectious specialists in theirnfield who have sought experts from around the world to help contribute chapters to this text. There is a lack of textbooks in this area, and having an authoritative work helps the field progress further, especially with the advances made since the last edition was published in 2003. Ali A Saherwala, MD(Thomas Jefferson University)


This second edition is a wonderful comprehensive reference for practicing neurologists and infectious disease specialists when faced with patients afflicted with viral-mediated neurological syndromes. A significant upgrade from the first edition, this edition includes newer topics, including West Nile, Ebola, Zika, enterovirus D68, and SARS-CoV-2 viruses, as well as significant advances in methodologies of detection and treatment. Drs. Nath and Berger have provided a very broad coverage to this topic, reflecting their clinical and scientific background, keeping both the clinical and scientific practitioners in mind. This text holds its own as a solidly comprehensive reference text for clinicians, including neurologists and infectious disease specialists, as well as for the immunologist and clinical scientist involved in the pathophysiology of virally mediated neurological illnesses. The editors are well-renowned neuroinfectious specialists in theirnfield who have sought experts from around the world to help contribute chapters to this text. There is a lack of textbooks in this area, and having an authoritative work helps the field progress further, especially with the advances made since the last edition was published in 2003. Ali A Saherwala, MD(Thomas Jefferson University)


This second edition is a wonderful comprehensive reference for practicing neurologists and infectious disease specialists when faced with patients afflicted with viral-mediated neurological syndromes. A significant upgrade from the first edition, this edition includes newer topics, including West Nile, Ebola, Zika, enterovirus D68, and SARS-CoV-2 viruses, as well as significant advances in methodologies of detection and treatment. Drs. Nath and Berger have provided a very broad coverage to this topic, reflecting their clinical and scientific background, keeping both the clinical and scientific practitioners in mind. This text holds its own as a solidly comprehensive reference text for clinicians, including neurologists and infectious disease specialists, as well as for the immunologist and clinical scientist involved in the pathophysiology of virally mediated neurological illnesses. The editors are well-renowned neuroinfectious specialists in theirnfield who have sought experts from around the world to help contribute chapters to this text. There is a lack of textbooks in this area, and having an authoritative work helps the field progress further, especially with the advances made since the last edition was published in 2003. Ali A Saherwala, MD(Thomas Jefferson University)


Author Information

Avindra Nath Dr. Nath is the Chief of the Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke. He was previously Professor in the Department of Neurology and Director of the Division of Neuroimmunology and Neurological Infections at Johns Hopkins University. His career has been dedicated to studying the clinical manifestations, pathophysiology and developing treatment for brain infections since the beginning of the AIDS pandemic. He has traveled to several countries to study these infections including Liberia during the Ebola epidemic. He teaches medical students, residents and clinical fellows on CNS infections for which he has received several teaching awards. He frequently talks at grand rounds, seminars and conferences around the world on viral infections of the brain and has been teaching courses on viral encephalitis at the American Academy of Neurology for over 20 years. His laboratory research is focused mainly on retroviral infections particularly HIV infection. More recently, his laboratory is studying the pathophysiology of Ebola and Zika viruses. He is the past President of the International Society of Neurovirology (ISNV) and an elected member of the Association of American Physicians. He is the recipient of the Pioneer award from the ISNV and the Wybran award from the Society of Neuroimmune Pharmacology. Joseph R. Berger Dr. Berger, M.D., is Professor of Neurology and Associate Chief of the Multiple Sclerosis Division of the Department of Neurology at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. His career has been dedicated to the diagnosis, treatment and investigation of neuroinfectious and neuroinflammatory disorders. His foray into neuroinfectious diseases started with the investigation of the neurological complications of HIV/AIDS while at the University of Miami at the inception of the AIDS pandemic and an endowment there established the Whigham-Berger Endowed Chair, the first endowed chair for the study of the neurological complications of HIV/AIDS. Dr. Berger continued his research in HIV and PML while at the University of Kentucky where he was Chairman of the Department of Neurology from 1995 to 2013. With Dr. Robert Levy, he co-founded and co-chaired the international Neuroscience of HIV conference. He is a fellow of the American College of Physicians, American Academy of Neurology and the American Neurological Association. Among his many awards are the Pioneer Award from the International Society of Neurovirology and the Distinguished Teaching Award from the American Neurological Association.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List